AGHEMO, ALESSIO MICHELE

AGHEMO, ALESSIO MICHELE  

Universita' degli Studi di MILANO  

Mostra records
Risultati 1 - 20 di 147 (tempo di esecuzione: 0.003 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Immunosuppressive contribution of tumour-infiltrating B cells in human intrahepatic cholangiocarcinoma and their role in chemoimmunotherapy outcome 2025 Camisaschi, C.Erreni, M.Aghemo, A.Pressiani, T.Torzilli, G.Cassani, B.Lleo, A. + Article (author) -
Myosteatosis is closely associated with sarcopenia and significantly worse outcomes in patients with cirrhosis 2024 Lampertico, PietroMartini, SilviaAghemo, AlessioIavarone, MassimoTosetti, Giulia + Article (author) -
Palliative care in patients with hepatocellular carcinoma: Results from a survey among hepatologists and palliative care physicians 2024 Iavarone, MassimoCanova, LorenzoAlimenti, EleonoraAghemo, AlessioLampertico, Pietro + Article (author) -
Safety of Sofosbuvir-Based Direct-Acting Antivirals for Hepatitis C Virus Infection and Direct Oral Anticoagulant Co-Administration 2024 De Nicola, StellaD'Ambrosio, RobertaColella, ElisaFederico, AlessandroAghemo, AlessioLampertico, Pietro + Article (author) -
Role of artificial intelligence in staging and assessing of treatment response in MASH patients 2024 Lombardi, RosaFracanzani, Anna LudovicaRoncalli, MassimoAghemo, AlessioDi Tommaso, Luca + Article (author) -
Prevalence of HCV infection in Europe in the DAA era: Review 2024 D'Ambrosio, RobertaAnolli, Maria PAghemo, AlessioLampertico, Pietro + Article (author) -
Should Artificial Intelligence-based language models be allowed in developing scientific manuscripts? A debate between ChatGPT and the editors of Liver International 2023 Aghemo, AlessioValenti, Luca + Article (author) -
Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study 2023 Aghemo A.Hernandez J.Lampertico P.Mohamed R.Negro F.Rodriguez M. + Article (author) -
Detailed stratified GWAS analysis for severe COVID-19 in four European populations 2022 Mantovani, AlbertoZanella, AlbertoBandera, AlessandraCherubini, AlessandroProtti, AlessandroAghemo, AlessioLleo, AnaGori, AndreaFracanzani, Anna LudovicaRuello, AntonellaPesenti, AntonioHu, CinziaPaccapelo, CinziaCappadona, ClaudioGalimberti, DanielaScarpini, ElioParaboschi, Elvezia MariaMartinelli-Boneschi, FilippoPeyvandi, FloraBlasi, FrancescoMalvestiti, FrancescoGrasselli, GiacomoCostantino, GiorgioBaselli, GuidoTerranova, LeonardoCarrabba, MariaMiozzo, MonicaMontano, NicolaPreatoni, PaolettaBonfanti, PaoloGualtierotti, RobertaPelusi, SerenaBosari, SilvanoAliberti, StefanoRimoldi, ValeriaDuga, StefanoAsselta, RosannaValenti, Luca + Article (author) -
Dysmetabolism, Diabetes and Clinical Outcomes in Patients Cured of Chronic Hepatitis C: A Real-Life Cohort Study 2022 Valenti L.Pelusi S.Aghemo A.Pasulo L.Degasperi E.D'Ambrosio R.Zuccaro V.Giorgini A.Rumi M. G.Spinelli O.Colombo M. C.Menzaghi B.D'Arminio Monforte A.Bonfanti P.Lampertico P. + Article (author) -
High rates of sustained virological response despite premature discontinuation of directly acting antivirals in HCV-infected patients treated in a real-life setting 2021 Lombardi A.Colaneri M.D'Ambrosio R.Degasperi E.Dibenedetto C.Giorgini A.Pasulo L.Spinelli O.Re T.Rumi M.Aghemo A.Lampertico P.Soffredini R.Perbellini R.Gori A.Colpani M.Manini M.Lazzaroni S.De Nicola S.Angelini Zucchetti T.Rossotti R.Colella E.Magnani C.Mena M.Caramma I.Basilico C.Biagiotti S.Mazzone A.Saladino V.Menzaghi B.Rumi M.Fanetti I.Dibenedetto C.Zermiani P.Zuin M.D'Arminio Monforte A.Capretti A.Messina E.Colombo A. E.Bonfanti P.Conforti S.Menozzi F.Gritti S.Giani P. + Article (author) -
Is there an 'ideal' diet for patients with NAFLD? 2021 Valenti, LucaAghemo, Alessio + Article (author) -
Should individuals who have been cured of hepatitis C virus and their partners be allowed to donate blood? 2021 Aghemo A.Valenti L.Rumi M. G. + Article (author) -
COVID-19 and the liver: A 2021 update 2021 Aghemo A.Valenti L. + Article (author) -
Renal safety in 3264 HCV patients treated with DAA-based regimens : results from a large Italian real-life study 2020 Pasulo L.Giorgini A.Fanetti I.Aghemo A.Menzaghi B.Lombardi A.Spinelli O.D'Arminio Monforte A.Zuin M.Lampertico P. + Article (author) -
Comparison of three therapeutic regimens for genotype-3 hepatitis C virus infection in a large real-life multicentre cohort 2020 Lapadula G.Valsecchi M. G.Carriero C.Degasperi E.Pasulo L.Baiguera C.Menzaghi B.Lombardi A.Aghemo A.Rumi M. G.Valenti L.De Bona A.d'Arminio Monforte A.Bonfanti P.Perini P.Capretti A.Ciaccio A.Lampertico P. + Article (author) -
High rates of 30-day mortality in patients with cirrhosis and COVID-19 2020 Triolo M.Massironi S.Aghemo A.Pedaci M.Rimondi A.Rumi M. G.Bonfanti P.Lampertico P. + Article (author) -
S1pr2 is a key mediator of endoplasmic reticulum stress in NAFLD/ NASH pathogenesis 2020 Petti, LucianaLleo, AnaRestelli, SilviaDonadon, MatteoArena, VincenzoCorsetto, PaolaRizzo, Angela MariaAghemo, AlessioVetrano, Stefania + Article (author) -
COVID-19 and liver disease 2020 Aghemo A.Valenti L. + Article (author) -
High rate of sustained virological response with direct-acting antivirals in haemophiliacs with HCV infection : A multicenter study 2020 Lampertico P.Peyvandi F.Aghemo A. + Article (author) -